The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: Evidence from anti-GBM nephritis after renal transplantation

This publication has 24 references indexed in Scilit:

• Characterization of the 3′ half of the human type IV collagen α5 gene that is affected in the Alport syndrome
  Genomics, 1991
• Single base mutation in α5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome
  Genomics, 1991
• Identification of Mutations in the COL4A5 Collagen Gene in Alport Syndrome
  Science, 1990
• Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome.
  Proceedings of the National Academy of Sciences, 1990
• The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target
  Pediatric Nephrology, 1989
• ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY-MEDIATED NEPHRITIS COMPLICATING TRANSPLANTATION IN A PATIENT WITH ALPORTʼS SYNDROME
  Transplantation, 1988
• The clinical spectrum of hereditary nephritis
  Kidney International, 1985
• Absence of Goodpasture's Antigen in Male Patients With Familial Nephritis
  American Journal of Kidney Diseases, 1983
• Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis
  Kidney International, 1982
• Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies
  The Journal of Pediatrics, 1980